Uterine Cancer Study Act of 2025

# Uterine Cancer Study Act of 2025 Summary **What the Bill Would Do** The Uterine Cancer Study Act of 2025 would authorize a comprehensive study on uterine cancer in the United States. While specific details about the study's scope aren't provided in the available information, such legislation typically directs federal health agencies (usually the National Institutes of Health or Centers for Disease Control and Prevention) to research aspects of the disease—such as causes, prevention, treatment outcomes, or disparities in how different populations are affected. **Who It Affects** This bill would primarily affect uterine cancer patients and at-risk populations, as well as researchers and healthcare providers studying the disease. It could also have broader implications for public health policy and medical treatment recommendations based on the study's findings. **Current Status** The bill (HR 4396) is currently in committee, meaning it has been introduced but has not yet been voted on by the full House of Representatives.

It was sponsored by Representative Yvette Clarke, a Democrat from New York. For the bill to become law, it would need to pass through committee review, receive a House vote, pass the Senate, and be signed by the President.